Davita Inc
Article Abstract:
DaVita Inc.'s earnings should advance in 2003 and 2004 by 5% to 20-25% respectively. The company has a strong cash flow and repayment of debt is not yet due till 2006 but safety rank is below average and earnings predicatability only 5%, stock is suitbale for for risk-tolerant investorr.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
US Oncology
Article Abstract:
US Oncology which has invested in cancer care centers is expected to advance 15%-20% in share earnings by 2003 and 2004. Shares are ranked to outperform t he market .
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Davita Inc
Article Abstract:
DaVita Inc. expects to have its earnings advance in 2003 and 2004. Shares are timely with above average appreciation potential out to 2006-2008.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
User Contributions:
Comment about this article or add new information about this topic: